The board of directors of Samhällsbyggnadsbolaget i Norden has, on the basis of an authorization granted by the annual general meeting, resolved on a directed issue of class D shares and a directed issue of subordinated convertibles mandatorily convertible into class B shares, whereby the company raises proceeds of SEK 3.4 billion before issue costs.
Vinge has advised Scandic Hotels Group AB (publ) on a fully underwritten rights issue, which will provide Scandic with issue proceeds amounting up to approximately SEK 1,765 million before deduction of transaction costs, and on the agreement of new credit facilities amounting to SEK 1,400 million.
The board of directors of Hansa Biopharma has, on the basis of an authorisation granted from the annual general meeting, resolved on a directed new issue of shares, whereby Hansa Biopharma will raise proceeds of SEK 1.1 billion, before issue costs.
Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 185 million in issue proceeds.
Vinge advises Cinven’s portfolio company Partner in Pet Food, a leading European pet food manufacturer, in connection with its acquisition of the Doggy Group (“Doggy”).
Vinge advises the owners of Larodan AB in the sale of the company to ABITEC Corporation, a subsidiary in the listed corporate group Associated British Foods, plc (“ABF”).
Axcel has signed an agreement to aquire a majority ownership stake in AddPro, a Swedish leading provider of IT and cloud services. AddPro’s current management team and founders will reinvest in the company alongside Axcel.
